Breast Biopsy Market Outlook 2026–2035: Growth Drivers and Industry Forecast
Uncover key drivers, emerging technologies, and competitive movements shaping the remote cardiac rehab platforms market from 2026–2035 with trusted insights from The Business Research Company
Across 2026–2030, what is the expected market valuation path of the Breast Biopsy Market?
The breast biopsy market size has experienced robust growth in recent years. Forecasts indicate it will expand from $1.53 billion in 2025 to $1.65 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.5%. The historical growth can be ascribed to factors such as the limited availability of advanced biopsy systems, reliance on traditional surgical biopsy methods, increasing breast cancer incidence, growing hospital and diagnostic center infrastructure, and the adoption of ultrasound-guided procedures.
The breast biopsy market is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $2.17 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.2%. This anticipated growth during the forecast period stems from several factors, including ongoing technological progress in liquid biopsy and imaging-guided systems, heightened public awareness concerning early breast cancer identification, the proliferation of diagnostic centers and hospitals, the growing incorporation of AI and data analytics, and the evolution of personalized and precision medicine strategies. Key developments expected during this period encompass the wider acceptance of minimally invasive biopsy techniques, an uptick in the application of liquid biopsy methods, advancements in imaging-guided biopsy systems, the broadening of breast cancer diagnostic and screening initiatives, and a stronger emphasis on ensuring patient safety and precise sample collection.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19348&type=smp
Which Drivers Are Supporting The Rise Of The Breast Biopsy Market?
The escalating incidence of breast cancer is anticipated to propel the expansion of the breast biopsy market. Breast cancer, a malignant tumor forming in breast tissue cells, can metastasize to other body parts if not treated promptly. The growing prevalence of this condition is linked to factors such as increased life expectancy, advanced detection methods, and greater public awareness. A breast biopsy serves to obtain tissue samples from suspicious breast regions for diagnosing and characterizing breast cancer. For instance, in October 2025, Breastcancer.org, a US-based non-profit organization, reported an estimated 316,950 women are expected to be diagnosed with invasive breast cancer in 2025, in addition to approximately 59,080 new cases of non-invasive ductal carcinoma in situ (DCIS). Thus, the increasing prevalence of breast cancer is a significant driver for the growth of the breast biopsy market.
What Segments Are Identified Within The Structure Of The Breast Biopsy Market?
The breast biopsy market covered in this report is segmented –
1) By Type: Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits, Liquid Biopsy Instruments, Other Types
2) By Image Guided Technology: Magnetic Resonance Imaging (MRI) Guided Breast Biopsy, Ultrasound Guided Breast Biopsy, Mammography Guided Stereotactic Biopsy, Computed Tomography (CT) Guided Biopsy, Other Image Guided Technologies
3) By Procedure: Needle Breast Biopsy, Open Surgical Breast Biopsy, Liquid Breast Biopsy
4) By Application: Hospitals, Clinics, Diagnostic Centers, Other Applications
Subsegments:
1) By Biopsy Needles: Core Biopsy Needles, Fine Needle Aspiration (FNA) Needles, Vacuum-Assisted Biopsy Needles, Automatic Biopsy Needles
2) By Guidance Systems: Ultrasound Guidance Systems, MRI Guidance Systems, Stereotactic Guidance Systems, Tomosynthesis Guidance Systems
3) By Biopsy Tables: Adjustable Biopsy Tables, Specialty Biopsy Tables, Imaging-Compatible Biopsy Tables
4) By Localization Wires: Hookwire Localization Devices, Radioguided Localization Wires, Magnetic Seed Localization Systems
5) By Assay Kits: Breast Cancer Assay Kits, Biomarker Detection Kits, Genetic Testing Kits for Breast Cancer
6) By Liquid Biopsy Instruments: Circulating Tumor Cell (CTC) Isolation Devices, Plasma DNA Isolation Kits, Liquid Biopsy Analysis Systems
7) By Other Types: Biopsy Adhesives, Specimen Collection and Transport Devices, Patient Management Systems
What Long-Term Trends Are Expected To Shape The Future Of The Breast Biopsy Market?
Major companies engaged in the breast biopsy marker market are concentrating on creating advanced products, such as ultrasound-visible site markers, with the aim of improving lesion localization and reducing marker displacement during breast biopsy procedures. An ultrasound-visible site marker is a specifically engineered implantable device that enhances the visibility of biopsy sites during imaging and provides stable localization for future surgical intervention. As an example, in August 2023, Mammotome, a US-based company specializing in breast biopsy and localization technologies, launched HydroMark Plus. This new breast biopsy site marker offers superior lesion visibility on ultrasound, aiding radiologists and surgeons in accurately targeting biopsy sites while mitigating the risk of marker displacement during subsequent surgical procedures. Being the latest addition to Mammotome’s HydroMark portfolio, HydroMark Plus is designed for enhanced procedural reliability and is expected to be available nationwide in the U.S. by the end of the year. The product’s key attributes include high ultrasound conspicuity for easy detection, a minimized risk of movement within breast tissue, and suitability for various breast imaging and interventional workflows. These characteristics are intended to improve clinical outcomes and procedural confidence for both physicians and patients.
Which Key Market Players Are Investing In Expansion And Innovation Within The Breast Biopsy Market?
Major companies operating in the breast biopsy market are Siemens Healthineers AG, Fujifilm Holdings Corporation, Becton Dickinson and Company BD, Koninklijke Philips, GE HealthCare Technologies Inc, Hologic Inc, Merit Medical Systems, Argon Medical Devices, Canon Medical Systems Corporation, Devicor Medical Products Inc, Planmed Oy, Menarini-Silicon Biosystems, Seno Medical Instruments Inc, Dilon Technologies Inc, INRAD Inc, Promaxo Inc, Cook Medical LLC, Boston Scientific Corporation, Stryker Corporation, Intact Medical Corporation, Scion Medical Technologies LLC, Galini SRL, Ethicon Surgical Technologies, Encapsule Medical Devices LLC, Cardinal Health Inc, Olympus Corporation, F Hoffmann-La Roche Ltd, Biocept Inc.
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/breast-biopsy-global-market-report
Which Regions Are Poised For Strategic Growth In The Breast Biopsy Market?
North America was the largest region in the breast biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breast biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Breast Biopsy Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=19348&type=smp
Browse Through More Reports Similar to the Global Breast Biopsy Market 2026, By The Business Research Company
Biopsy Devices Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report
Liquid Biopsy For Cancer Diagnostics Global Market Report 2026
Smart Biopsy Devices Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
